vaccines

News

Moderna eyes 2025 approval for COVID, flu combination jab

Moderna’s combined mRNA-based vaccine for COVID-19 and seasonal influenza has been shown to be at least as effective as jabs given separately in a phase 1/2 trial, setting

News

Novavax gets green light for updated COVID vaccine

Novavax has been given the go-ahead by regulators in the US for an updated version of its COVID-19 vaccine that targets the XBB.1.5 variant of the coronavirus.

News

Sanofi partners J&J on E. coli vaccine

Sanofi is paying $175 million upfront to claim a share of an experimental vaccine developed by Johnson & Johnson’s pharma unit Janssen that aims to tackle a major caus

News

WHO clears Oxford malaria jab for immunisation programmes

The World Health Organization (WHO) has recommended the use of a malaria vaccine developed at Oxford University in the UK, after concluding it is 75% effective at protecti

News

CureVac claims advantage in BioNTech patent dispute

A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba

News

US researchers start trials of universal flu vaccine

Researchers at the National Institutes of Health (NIH) have started dosing patients in a phase 1 trial of a new influenza vaccine candidate that aims to sidestep the annua

Moderna eyes 2025 approval for COVID, flu combination jab

Novavax gets green light for updated COVID vaccine

Sanofi partners J&J on E. coli vaccine

WHO clears Oxford malaria jab for immunisation programmes

CureVac claims advantage in BioNTech patent dispute

US researchers start trials of universal flu vaccine

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

vaccines

Editor's Picks